- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03906240
Pilot Study Testing a Web-Based Moral Elevation Intervention for Veterans With PTSD and Moral Injury
June 12, 2024 updated by: VA Office of Research and Development
Using Moral Elevation to Improve Functioning in Veterans With PTSD and Moral Injury: A Pilot Study of a Web-Based Intervention
Given the prevalence of posttraumatic stress disorder (PTSD) and moral injury in combat Veterans and the limitations to current treatments, novel approaches are needed to target both PTSD and moral injury and directly impact psychosocial growth and functional recovery.
One potential way to address this critical need is through moral elevation-a positive emotional state described as feeling uplifted and inspired by others' virtuous actions.
This study will pilot a web-based moral elevation intervention with Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans who experienced a morally injurious event and with a PTSD diagnosis.
If Veterans are willing and able to complete an online moral elevation intervention and it has beneficial effects, then moral elevation could be feasibly utilized as a tool to reverse the negative effects of trauma and facilitate recovery.
Data from this study will be used to develop larger clinical trials to test if this intervention significantly improves PTSD symptoms and moral injury distress and enhances social functioning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The goal of this proposed study is to conduct a pilot trial of a web-based moral elevation intervention to determine if such an intervention is a feasible and acceptable therapeutic approach for Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans with distress related to posttraumatic stress disorder (PTSD) and moral injury (MI).
This study will also assess the feasibility of randomization, retention, and completion of a no-treatment condition (i.e., comparison group) in preparation for future randomized controlled trials (RCTs).
The sample will include 24 Veterans (12 per group).
The online intervention consists of two exercises per week for one month, totaling eight sessions.
Sessions will include watching validated videos that elicit moral elevation and recalling moments when one experienced moral elevation in daily life, paired with journaling about one's reactions to witnessed virtuous behavior.
Participants in the intervention condition will also be presented with a brief goal to be completed prior to the next session to facilitate greater social engagement.
Participants randomized to the no-treatment condition will access the same online portal twice per week, but will not be exposed to any intervention components.
All participants will complete brief self-report measures at each online session.
All participants will also complete self-report measures at baseline and 1-month follow-up that will assess PTSD symptoms, MI distress, prosocial behavior, and quality of social relationships.
At the follow-up assessment, participants randomized to the intervention condition will complete an individual qualitative interview with a member of the study team to assess acceptability and satisfaction with the intervention and proposed methodology, which will be coded and analyzed to inform future clinical trials.
To supplement self-report measures, all participants will invite a significant other (e.g., spouse, close friend) to complete measures based on observations of the Veteran's behavior and social functioning at baseline and 1-month follow-up.
Feasibility of recruitment, retention, and completion of the intervention will be analyzed by tracking the number of participants retained at each stage of the study, as well as the number of sessions completed in the intervention.
Results from this study will be used to develop an RCT with a larger sample size to determine the efficacy of a moral elevation intervention and assess whether this novel approach leads to unique beneficial outcomes regarding PTSD and moral injury distress.
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Temple, Texas, United States, 76504
- Central Texas Veterans Health Care System, Temple, TX
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Veteran Participant Inclusion Criteria:
- 18 years of age
- OEF/OIF/OND Veteran enrolled in CTVHCS
- English-speaking and able to provide written informed consent
- Internet access for web-based sessions and measures
- Current PTSD diagnosis based on medical chart review or screen positively for a probable diagnosis based on empirically-validated cutoffs on the PTSD Checklist for DSM-5
- Screen positively for experiencing 1 morally injurious event and endorse some distress (>4 on any item) related to that event based on the Moral Injury Events Scale (MIES)
- Willing to complete study procedures and identify an SO who will complete observational measures
- Willing to be randomized
Significant Other Participant Inclusion Criteria:
- 18 years of age
- Designated as a Significant Other by the Veteran participant, and the Veteran participant has provided consent for the study team to contact that potential Significant Other
- English-speaking
- Internet access for web-based observational measures
- Interact with the Veteran >1 time per week
- Willing to complete study procedures
Exclusion Criteria:
Veteran Participant Exclusion Criteria:
- History of severe traumatic brain injury indicated by medical review and the Ohio State Traumatic Brain Injury Identification Method (OSU TBI-ID)
- Psychosis or current substance use disorder indicated by medical review and the Mini International Neuropsychiatric Interview (MINI)
- Current suicide risk based on the Beck Depression Inventory-II (BDI-II)
Significant Other Participant Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No intervention
Veterans will access the online portal and complete session measures, but will not be presented with any intervention content (i.e., videos, journaling exercise, and goal setting exercise)
|
|
|
Experimental: Moral Elevation Intervention
Moral Elevation Intervention (described in intervention section).
|
The intervention will be administered twice per week for 8 sessions total.
The intervention will include two types of moral elevation exercises related to witnessing virtuous behavior and subsequently setting session goals aimed to facilitate social engagement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Evaluation Inventory-Short Form (TEI-SF)
Time Frame: Follow-up assessment within 1 week of study completion.
|
The TEI-SF is a 9-item self-report measure that assessed acceptability of the moral elevation intervention and its procedure.
Items were scored from 1 to 5, with higher scores indicating greater acceptability.
To assess the acceptability of the treatment in this study, we calculated descriptive statistics to determine the average score for each item across the intervention condition.
The mid-point item score for this measure (range = 1-5, mid-point = 3) was used as an indicator for adequate acceptability (e.g., average/medium levels of acceptability, or higher).
Thus, item scores that were greater than 3 are interpreted as supporting medium to high perceived acceptability of the intervention.
|
Follow-up assessment within 1 week of study completion.
|
|
Exercise-Specific Satisfaction Survey (ESSS)
Time Frame: Repeated measure administered during online sessions 1-8 (every Monday & Thursday for 4 weeks of study participation). Participant scores for each item were averaged across all 8 sessions/measurements.
|
The ESSS is a 4-item self-report measure that assessed acceptability of and satisfaction with the moral elevation exercises within the intervention condition.
Items are scored from 0 to 8 with higher scores indicate greater perceived helpfulness and satisfaction with moral elevation exercises.
To assess the satisfaction of the session components, we calculated descriptive statistics to determine the average score for each item across all 8 sessions (e.g., average score of item #1 for 8 repeated measurements across 8 sessions).
The mid-point item score for this measure (range = 0-8, mid-point = 4) was used as an indicator for adequate satisfaction.
Thus, item scores that were greater than 4 are interpreted as supporting medium to high perceived satisfaction of the intervention.
|
Repeated measure administered during online sessions 1-8 (every Monday & Thursday for 4 weeks of study participation). Participant scores for each item were averaged across all 8 sessions/measurements.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Elevation Scale (ES)
Time Frame: Repeated measure administered during online sessions 1-8 (every Monday & Thursday for 4 weeks of study participation). Participant scores were averaged across all 8 sessions/measurements.
|
The ES is a 12-item self-report measure of the degree to which state-level moral elevation is experienced.
Items are scored from 0 to 4. Scores on 12 items were averaged to create a mean item score ranging from 0 to 4. Higher total scores indicate higher levels of state moral elevation.
To assess the level of elevation elicited in sessions, we calculated descriptive statistics to determine the average elevation score for 8 repeated measurements across 8 sessions.
The mid-point item score for this measure (range = 0-4, mid-point = 2) was used as an indicator for adequate elevation.
Thus, an average elevation score that was greater than 2 is interpreted as supporting medium to high levels of elevation elicited in intervention sessions.
|
Repeated measure administered during online sessions 1-8 (every Monday & Thursday for 4 weeks of study participation). Participant scores were averaged across all 8 sessions/measurements.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in Posttraumatic Checklist for DSM-5 (PCL-5)
Time Frame: Administered at baseline and follow-up assessment within 1 week of study completion.
|
The PCL-5 is a 20-item self-report measure that assessed PTSD symptom severity.
Items were scored from 0 to 4 and summed to create a total score ranging from 0 to 80. Higher scores indicate greater symptom severity.
Reported findings indicate changes in PCL-5 from baseline to follow-up across both conditions.
Reported findings in the Outcome Measure Data Table represent PCL-5 scores at baseline and follow up assessments within each condition.
|
Administered at baseline and follow-up assessment within 1 week of study completion.
|
|
Changes From Baseline in Expression of Moral Injury Scale-Military Version (EMIS-M)
Time Frame: Administered at baseline and follow-up assessment within 1 week of study completion.
|
The EMIS-M is a 17-item self-report measure of expressions of distress related to a moral injury directed at both self and others.
Items were scored from 1 to 5 and summed to create a total score ranging from 17 to 85. Higher scores indicate greater moral injury-related distress.
Reported findings in the Outcome Measure Data Table represent EMIS-M scores at baseline and follow-up assessments within each condition.
|
Administered at baseline and follow-up assessment within 1 week of study completion.
|
|
Changes From Baseline in World Health Organization Quality of Life (WHOQOL-BREF)
Time Frame: Administered at baseline and follow-up assessment within 1 week of study completion.
|
The WHOQOL-BREF is a 26-item self-report measure of overall quality of life with 4 domains (physical health, psychological health, social relationships, and environment) and was used to assess perceptions of psychological health and quality of social relationships.
Subscales scores are computed by summing all items for each subscale, then all scores are transformed to a range of 0-100.
A higher score signifies higher or better quality of life.
Reported findings in the Outcome Measure Data Table represent the WHOQOL-BREF subscale scores at baseline and follow up assessments within each condition.
|
Administered at baseline and follow-up assessment within 1 week of study completion.
|
|
Changes From Baseline in Prosocialness Scale (PS) - Self-report
Time Frame: Administered at baseline and follow-up assessment within 1 week of study completion.
|
The PS is a 16-item measure that was completed by Veterans (self-report) to assess their prosocial behaviors and tendencies to help others.
Items were scored from 1 to 5 and summed to create a total score ranging from 16 to 80. Higher scores indicate greater prosocial behavior.
Reported findings in the Outcome Measure Data Table represent PS scores at baseline and follow-up assessments within each condition.
|
Administered at baseline and follow-up assessment within 1 week of study completion.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Adam P. McGuire, PhD, Central Texas Veterans Health Care System, Temple, TX
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2020
Primary Completion (Actual)
November 30, 2021
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
March 27, 2019
First Submitted That Met QC Criteria
April 3, 2019
First Posted (Actual)
April 8, 2019
Study Record Updates
Last Update Posted (Actual)
June 13, 2024
Last Update Submitted That Met QC Criteria
June 12, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3035-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All collected IPD
IPD Sharing Time Frame
1 year after publication
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
Sofie FolkeAarhus University Hospital; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsNot yet recruiting
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
ARQ National Psychotrauma CentreLeiden University Medical CenterEnrolling by invitationPosttraumatic Stress Disorder (PTSD)Netherlands
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Anthony VescoNorthwestern University Feinberg School of Medicine; Substance Abuse and Mental...Not yet recruitingPosttraumatic Stress Disorders | Trauma | Posttraumatic Stress Symptoms | Chronic Medical Conditions | Chronic Medical Illness | Trauma Exposure | Chronic Medical Condition | Posttraumatic Stress | Posttraumatic Stress Disorder PTSD | Mental Health Functioning | Trauma and Stressor Related DisorderUnited States
Clinical Trials on Moral Elevation intervention
-
VA Office of Research and DevelopmentNot yet recruitingPosttraumatic Stress DisorderUnited States
-
I-Shou UniversityCompletedSchizophrenia | Violence | Moral StatusTaiwan
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedBurnout, Professional | Caregiver ExhaustionNetherlands
-
Unity Health TorontoMcMaster University; University of Toronto; Ryerson University; University of Ontario...CompletedDistress, Emotional | Moral InjuryCanada
-
VA Office of Research and DevelopmentCompletedAntisocial Personality Disorder | Substance Use DisorderUnited States
-
VA Office of Research and DevelopmentVA Palo Alto Health Care SystemCompleted
-
Misr International UniversitySuez Canal UniversityCompletedMarginal Bone Levels | Open Sinus Elevation | Closed Sinus ElevationEgypt
-
Fundación de Investigación Biomédica - Hospital...Not yet recruiting
-
IRCCS San RaffaeleUniversità Vita-Salute San RaffaeleCompletedHealthy Controls | Moral Development | Moral Dilemma | Moral JustificationItaly
-
Northwestern UniversityNational Institute of Mental Health (NIMH)CompletedDepression - Major Depressive DisorderUnited States